Fingerprint
Dive into the research topics of 'Phosphodiesterase-5 inhibitor therapy for pulmonary hypertension in the United States actual versus recommended use'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Phosphodiesterase-5 inhibitor therapy for pulmonary hypertension in the United States actual versus recommended use
Deborah Kim, Kyung Min Lee, Marc R. Freiman, W. Ryan Powell, Elizabeth S. Klings, Seppo T. Rinne, Donald R. Miller, Adam J. Rose, Renda Soylemez Wiener*
*Corresponding author for this work
Research output: Contribution to journal › Article › peer-review
26
Scopus
citations